Coexistence of hepatitis B surface antigen and anti-HBs in Chinese chronic hepatitis B virus patients relating to genotype C and mutations in the S and P gene reverse transcriptase region

Archives of Virology

Volumn 157, Issue 4, 2012, Pages 627-634

  Liu, Weiwei ^a   Hu, Tingting ^a   Wang, Xinyu ^b   Chen, Yuming ^a   Huang, Minying ^a   Yuan, Chao ^a   Guan, Ming ^a,b  

^a FUDAN UNIVERSITY   (China)

^b FUDAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B ANTIBODY; HEPATITIS B SURFACE ANTIGEN; P PROTEIN, HEPATITIS B VIRUS; POL PROTEIN; S ENVELOPE PROTEIN, HEPATITIS B VIRUS; VIRUS DNA; VIRUS ENVELOPE PROTEIN;

ADOLESCENT; ADULT; AGED; AMINO ACID SUBSTITUTION; ARTICLE; BLOOD; CHEMISTRY; CHINA; DNA SEQUENCE; FEMALE; GENETICS; GENOTYPE; GROWTH, DEVELOPMENT AND AGING; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; IMMUNOLOGY; MALE; MIDDLE AGED; MISSENSE MUTATION; VIROLOGY;

ADOLESCENT; ADULT; AGED; AMINO ACID SUBSTITUTION; CHINA; DNA, VIRAL; FEMALE; GENE PRODUCTS, POL; GENOTYPE; HEPATITIS B ANTIBODIES; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; MALE; MIDDLE AGED; MUTATION, MISSENSE; SEQUENCE ANALYSIS, DNA; VIRAL ENVELOPE PROTEINS; YOUNG ADULT;

HEPATITIS B VIRUS;

EID: 84859099473     PISSN: 03048608     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00705-011-1215-5     Document Type: Article

References (25)

1. Fattovich G, Brollo L, Giustina G, Noventa F, Pontisso P, Alberti A, Realdi G, Ruol A (1991) Natural history and prognostic factors for chronic hepatitis type B. Gut 32: 294-298.
2. Liaw YF, Tai DI, Chu CM, Chen TJ (1988) The development of cirrhosis in patients with chronic type B hepatitis: a prospective study. Hepatology 8: 493-496.
3. Beasley RP, Hwang LY, Lin CC, Chien CS (1981) Hepatocellular carcinoma and hepatitis B virus: a prospective study of 22 707 men in Taiwan. Lancet 2: 1129-1133.
4. Yang R, Cong X, Xu Z, Xu D, Huang W, Maertens R, Wei L (2010) INNO-LiPA HBV genotyping is highly consistent with direct sequencing and sensitive in detecting B/C mixed genotype infection in Chinese chronic hepatitis B patients and asymptomatic HBV carriers. Clin Chim Acta 411: 1951-1956.
5. Lada O, Benhamou Y, Poynard T, Thibault V (2006) Coexistence of hepatitis B surface antigen (HBs Ag) and anti-HBs antibodies in chronic hepatitis B virus carriers: influence of "a" determinant variants. J Virol 80: 2968-2975.
6. Zhang JM, Xu Y, Wang XY, Yin YK, Wu XH, Weng XH, Lu M (2007) Coexistence of hepatitis B surface antigen (HBsAg) and heterologous subtype-specific antibodies to HBsAg among patients with chronic hepatitis B virus infection. Clin Infect Dis 44: 1161-1169.
7. Colson P, Borentain P, Motte A, Henry M, Moal V, Botta-Fridlund D, Tamalet C, Gerolami R (2007) Clinical and virological significance of the co-existence of HBsAg and anti-HBs antibodies in hepatitis B chronic carriers. Virology 367: 30-40.
8. Huang X, Qin Y, Zhang P, Tang G, Shi Q, Xu J, Qi F, Shen Q (2010) PreS deletion mutations of hepatitis B virus in chronically infected patients with simultaneous seropositivity for hepatitis-B surface antigen and anti-HBS antibodies. J Med Virol 82: 23-31.
9. Zheng X, Weinberger KM, Gehrke R, Isogawa M, Hilken G, Kemper T, Xu Y, Yang D, Jilg W, Roggendorf M, Lu M (2004) Mutant hepatitis B virus surface antigens (HBsAg) are immunogenic but may have a changed specificity. Virology 329: 454-464.
10. Yukimasa N, Ohkushi H, Fukasawa K, Fukuchi K, Takagi Y, Gomi K (2000) Hepatitis B virus gene mutations in the sera of three patients with coexisting hepatitis B surface antigen and anti-surface antibody. Rinsho Byori 48: 184-188.
11. Weber B (2005) Genetic variability of the S gene of hepatitis B virus: clinical and diagnostic impact. J Clin Virol 32: 102-112.
12. Wang YM, Ng WC, Lo SK (1999) Detection of pre-S/S gene mutants in chronic hepatitis B carriers with concurrent hepatitis B surface antibody and hepatitis B surface antigen. J Gastroenterol 34: 600-606.
13. Shiels MT, Taswell HF, Czaja AJ, Nelson C, Swenke P (1987) Frequency and significance of concurrent hepatitis B surface antigen and antibody in acute and chronic hepatitis B. Gastroenterology 93: 675-680.
14. Konopnicki D, Mocroft A, de Wit S, Antunes F, Ledergerber B, Katlama C, Zilmer K, Vella S, Kirk O, Lundgren JD (2005) Hepatitis B and HIV: prevalence, AIDS progression, response to highly active antiretroviral therapy and increased mortality in the EuroSIDA cohort. AIDS 19: 593-601.
15. Kao JH, Chen PJ, Lai MY, Chen DS (2000) Hepatitis B genotypes correlate with clinical outcomes in patients with chronic hepatitis B. Gastroenterology 118: 554-559.
16. Carman WF (1997) The clinical significance of surface antigen variants of hepatitis B virus. J Viral Hepat 4(Suppl 1): 11-20.
17. Suwannakarn K, Tangkijvanich P, Thawornsuk N, Theamboonlers A, Tharmaphornpilas P, Yoocharoen P, Chongsrisawat V, Poovorawan Y (2008) Molecular epidemiological study of hepatitis B virus in Thailand based on the analysis of pre-S and S genes. Hepatol Res 38: 244-251.
18. Lu M, Lorentz T (2003) De novo infection in a renal transplant recipient caused by novel mutants of hepatitis B virus despite the presence of protective anti-hepatitis B surface antibody. J Infect Dis 187: 1323-1326.
19. Cooreman MP, Leroux-Roels G, Paulij WP (2001) Vaccine- and hepatitis B immune globulin-induced escape mutations of hepatitis B virus surface antigen. J Biomed Sci 8: 237-247.
20. Coleman PF (2006) Detecting hepatitis B surface antigen mutants. Emerg Infect Dis 12: 198-203.
21. Chen CH, Hung CH, Lee CM, Hu TH, Wang JH, Wang JC, Lu SN, Changchien CS (2007) Pre-S deletion and complex mutations of hepatitis B virus related to advanced liver disease in HBeAg-negative patients. Gastroenterology 133: 1466-1474.
22. Choi MS, Kim DY, Lee DH, Lee JH, Koh KC, Paik SW, Rhee JC, Yoo BC (2007) Clinical significance of pre-S mutations in patients with genotype C hepatitis B virus infection. J Viral Hepat 14: 161-168.
23. Sugauchi F, Ohno T, Orito E, Sakugawa H, Ichida T, Komatsu M, Kuramitsu T, Ueda R, Miyakawa Y, Mizokami M (2003) Influence of hepatitis B virus genotypes on the development of preS deletions and advanced liver disease. J Med Virol 70: 537-544.
24. Lin CL, Liu CH, Chen W, Huang WL, Chen PJ, Lai MY, Chen DS, Kao JH (2007) Association of pre-S deletion mutant of hepatitis B virus with risk of hepatocellular carcinoma. J Gastroenterol Hepatol 22: 1098-1103.
25. Shi ZJ, Yang YB, Ma L, Li XM, Schreiber A (2010) Lamivudine in late pregnancy to interrupt in utero transmission of hepatitis B virus: a systematic review and meta-analysis. Obstet Gynecol 116: 147-159.